>Pharma conpanies want therapies to work because billing insurance companies at scale is where the money is, not individual patients. I mean that's wrong becau

>Pharma conpanies want therapies to work because billing insurance companies at scale is where the money is, not individual patients. I mean that's wrong because the article directly states that they're charging lots of money for this therapy so that they have an incentive. If 'the real money' was in insurance at scale, why does NurOwn require an additional monetary incentive beyond free test cases? Obviously they care about being able to bill individual patients. Especially in right-to-try cases because the type of person willing to pay to try an experimental therapy is often the type of person who would hand you everything they own. >The result of blocking this is to say that dying patients should just die, tough shit, but hey at least they will die with more money right? Most of these people are going to die anyway and many will now die experiencing side effects they had no way of knowing about. They'll also leave their families nothing. Marketizing healthcare has already raced us to an ugly bottom. This law creates a new and even lower bottom to how pharmaceutical companies are able to take advantage of some of the most desperate people our society has. That's not a good thing.